These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex. Fohlen M; Ferrand-Sorbets S; Delalande O; Dorfmüller G Childs Nerv Syst; 2018 Aug; 34(8):1511-1519. PubMed ID: 29766265 [TBL] [Abstract][Full Text] [Related]
4. Subependymal giant-cell astrocytoma: A surgical review in the modern era of mTOR inhibitors. Danassegarane G; Tinois J; Sahler Y; Aouaissia S; Riffaud L Neurochirurgie; 2022 Dec; 68(6):627-636. PubMed ID: 35907444 [TBL] [Abstract][Full Text] [Related]
5. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309 [TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694 [TBL] [Abstract][Full Text] [Related]
7. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review. Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938 [TBL] [Abstract][Full Text] [Related]
8. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation. Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282 [TBL] [Abstract][Full Text] [Related]
9. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex. Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057 [TBL] [Abstract][Full Text] [Related]
10. [Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature]. Adachi M; Nakamura M; Shinozaki N; Miyazaki T No Shinkei Geka; 2017 May; 45(5):397-404. PubMed ID: 28490681 [TBL] [Abstract][Full Text] [Related]
11. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA). Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement? Gaillard AL; Crombé A; Jecko V; Bessou P; Havez M; Pédespan JM; Van Gils J; Chateil JF Pediatr Radiol; 2020 Sep; 50(10):1397-1408. PubMed ID: 32671416 [TBL] [Abstract][Full Text] [Related]
13. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors. Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001 [TBL] [Abstract][Full Text] [Related]
14. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)]. Ichikawa T; Niida Y No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091 [TBL] [Abstract][Full Text] [Related]
16. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex. Jiang T; Du J; Raynald ; Wang J; Li C World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062 [TBL] [Abstract][Full Text] [Related]
17. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility. Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976 [TBL] [Abstract][Full Text] [Related]
18. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? de Ribaupierre S; Dorfmüller G; Bulteau C; Fohlen M; Pinard JM; Chiron C; Delalande O Neurosurgery; 2007 Jan; 60(1):83-89; discussion 89-90. PubMed ID: 17228255 [TBL] [Abstract][Full Text] [Related]
19. The cystic growth of a subependymal giant-cell astrocytoma with tuberous sclerosis. Sugita Y; Taguchi A; Miyagi J; Yuge T; Tomita T; Shigemori M; Morimatsu M Kurume Med J; 1992; 39(2):123-8. PubMed ID: 1405432 [TBL] [Abstract][Full Text] [Related]
20. Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus. Arroyo MS; Krueger DA; Broomall E; Stevenson CB; Franz DN Pediatr Neurol; 2017 Jul; 72():81-85. PubMed ID: 28511812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]